RE: Deal/Sale13 Jul 2023 16:36
Exactly they are waiting for the repeat data, it would be madness to approach likely pharma licensee's until you have the full set - partic if its weeks away. Given the crucial congress is in Sept that will mark the start date of the main effort. They have had contact with Kissei in depth leading to a near deal back in 2020, & possibly some feelers out others since but the whole point of waiting for the full data set is exactly that: get the full set then approach the most likely candidates. Those figures for for licensee discussions seem way way over optimistic compared to the timescales I have seen other small bio's take. Everything takes longer in practice than in theory.
I think you are reading way too much short term optimism into Dan's generally bullish pronouncements (this again is a recurring theme over the years & in that the past does replicate the present). You hope for this year, I see it 1H 2024 - we will find out who is closer to the truth, and to be clear, I hope its you & we can have a good Xmas.